{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:56:05Z","timestamp":1648677365398},"reference-count":7,"publisher":"Japanese Society of Internal Medicine","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med","J. Jpn. Soc. Intern. Med."],"published-print":{"date-parts":[[2014]]},"DOI":"10.2169\/naika.103.681","type":"journal-article","created":{"date-parts":[[2015,3,9]],"date-time":"2015-03-09T18:07:29Z","timestamp":1425924449000},"page":"681-686","source":"Crossref","is-referenced-by-count":0,"title":["1. The Pathophysiology of Heart Failure-Is It the Disease of the Heart?-"],"prefix":"10.2169","volume":"103","author":[{"given":"Masafumi","family":"Kitakaze","sequence":"first","affiliation":[{"name":"Department of Clinical Medicine and Development and Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1) Poole-Wilson PA: History, definition, and classification of heart failure. Poole-Wilson PA, et al, eds. In Heart failure, Churchill Livingstone, NY, 1997, 269-277."},{"key":"2","unstructured":"4) Feldman A, et al for the VesT Investigators: Mechanism of increased mortality from vesnarinone in the severe heart failure trial (VesT). J Am Coll Cardiol 29 (suppl A): 64A, 1997."},{"key":"3","doi-asserted-by":"crossref","unstructured":"5) The SOLVD Investigators: Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med Aug 325: 293-302, 1991.","DOI":"10.1056\/NEJM199108013250501"},{"key":"4","doi-asserted-by":"publisher","unstructured":"6) Pitt B, et al: Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial-the Losartan Heart Failure Survival Study ELITE II. Lancet 355: 1582-1587, 2000.","DOI":"10.1016\/S0140-6736(00)02213-3"},{"key":"5","doi-asserted-by":"crossref","unstructured":"7) Waagstein F, et al: Effect of chronic beta-adrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37: 1022-1036, 1975.","DOI":"10.1136\/hrt.37.10.1022"},{"key":"6","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1161\/01.CIR.90.4.1765","volume":"90","author":"CIBIS Investigators and Committees null","year":"1994","unstructured":"8) CIBIS Investigators and Committees: A randomized trial of \u03b2-blockade in heart failure: The cardiac insufficiency bisoprolol study. Circulation 90: 1765-1773, 1994.","journal-title":"Circulation","ISSN":"http:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"7","doi-asserted-by":"crossref","unstructured":"9) Packer M, et al: The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure. N Engl J Med 334: 1349-1355, 1996.","DOI":"10.1056\/NEJM199605233342101"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":["1\uff0e\u5fc3\u4e0d\u5168\u306f\u5fc3\u81d3\u306e\u75c5\u6c17\u304b\uff1f"],"language":"en","deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T16:21:15Z","timestamp":1566404475000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/103\/3\/103_681\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.103.681","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}